- lobal pharmaceutical output surged in 2025 due to preemptive production ahead of U.S. tariff actions, with a 9.1% increase in manufacturing output.
- The pharmaceutical sector benefits from structural resilience, stable demand, and strong credit conditions, supporting long-term investment despite economic uncertainties.....[PharmExec]